Author:
Ohashi Yuichi,Protack Clinton D.,Aoyagi Yukihiko,Gonzalez Luis,Thaxton Carly,Zhang Weichang,Kano Masaki,Bai Hualong,Yatsula Bogdan,Alves Rafael,Hoshina Katsuyuki,Schneider Eric B.,Long Xiaochun,Perry Rachel J.,Dardik Alan
Abstract
AbstractClinical outcomes of arteriovenous fistulae (AVF) for hemodialysis remain inadequate since biological mechanisms of AVF maturation and failure are still poorly understood. Aortocaval fistula creation (AVF group) or a sham operation (sham group) was performed in C57BL/6 mice. Venous limbs were collected on postoperative day 7 and total RNA was extracted for high throughput RNA sequencing and bioinformatic analysis. Genes in metabolic pathways were significantly downregulated in the AVF, whereas significant sex differences were not detected. Since gene expression patterns among the AVF group were heterogenous, the AVF group was divided into a ‘normal’ AVF (nAVF) group and an ‘outliers’ (OUT) group. The gene expression patterns of the nAVF and OUT groups were consistent with previously published data showing venous adaptive remodeling, whereas enrichment analyses showed significant upregulation of metabolism, inflammation and coagulation in the OUT group compared to the nAVF group, suggesting the heterogeneity during venous remodeling reflects early gene expression changes that may correlate with AVF maturation or failure. Early detection of these processes may be a translational strategy to predict fistula failure and reduce patient morbidity.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC